SURGALIGN HOLDINGS INC (SRGA) Stock Price & Overview
NASDAQ:SRGA • US86882C2044
Current stock price
The current stock price of SRGA is 0.1829 USD. Today SRGA is down by -32.98%. In the past month the price decreased by -75.93%. In the past year, price decreased by -94.35%.
SRGA Key Statistics
- Market Cap
- 1.68M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -5.81
- Dividend Yield
- N/A
SRGA Stock Performance
SRGA Stock Chart
SRGA Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to SRGA. When comparing the yearly performance of all stocks, SRGA is a bad performer in the overall market: 99.87% of all stocks are doing better.
SRGA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to SRGA. SRGA may be in some trouble as it scores bad on both profitability and health.
SRGA Earnings
SRGA Forecast & Estimates
10 analysts have analysed SRGA and the average price target is 2.3 USD. This implies a price increase of 1154.78% is expected in the next year compared to the current price of 0.1829.
For the next year, analysts expect an EPS growth of -58.25% and a revenue growth -37.13% for SRGA
SRGA Groups
Sector & Classification
SRGA Financial Highlights
Over the last trailing twelve months SRGA reported a non-GAAP Earnings per Share(EPS) of -5.81. The EPS increased by 50.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
SRGA Ownership
SRGA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 28.63 | 57.264B | ||
| COO | COOPER COS INC/THE | 13.99 | 13.796B | ||
| ALGN | ALIGN TECHNOLOGY INC | 15.05 | 12.563B | ||
| SOLV | SOLVENTUM CORP | 10.01 | 11.648B | ||
| LNTH | LANTHEUS HOLDINGS INC | 14.15 | 5.039B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 16.1 | 4.061B | ||
| ICUI | ICU MEDICAL INC | 15.15 | 3.126B | ||
| HAE | HAEMONETICS CORP/MASS | 10.9 | 2.737B | ||
| XRAY | DENTSPLY SIRONA INC | 7.47 | 2.249B | ||
| NEOG | NEOGEN CORP | 24.65 | 1.893B | ||
| UFPT | UFP TECHNOLOGIES INC | 18.74 | 1.519B | ||
| STAA | STAAR SURGICAL CO | 123.96 | 868.958M | ||
| BVS | BIOVENTUS INC - A | 11.06 | 744.84M |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SRGA
Company Profile
Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 217 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing artificial intelligence (AI) and augmented reality (AR) technology platform called HOLO AI, which is an AI software technology, which connects the continuum of care from the pre-op and clinical-stage through post-op care. Its HOLO Portal surgical guidance system, a component of its HOLO AI technology platform, is designed to automatically recognize, identify, and segment patient anatomy to autonomously assist the surgeon throughout the surgical procedure. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. Its market and sell products to hospitals, ambulatory surgery centers, and healthcare providers in the United States.
Company Info
IPO: 2000-08-10
SURGALIGN HOLDINGS INC
520 Lake Cook Rd Ste 315
Deerfield ILLINOIS 60015 US
CEO: Terry M. Rich
Employees: 217
Phone: 18773436832.0
SURGALIGN HOLDINGS INC / SRGA FAQ
What does SURGALIGN HOLDINGS INC do?
Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 217 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing artificial intelligence (AI) and augmented reality (AR) technology platform called HOLO AI, which is an AI software technology, which connects the continuum of care from the pre-op and clinical-stage through post-op care. Its HOLO Portal surgical guidance system, a component of its HOLO AI technology platform, is designed to automatically recognize, identify, and segment patient anatomy to autonomously assist the surgeon throughout the surgical procedure. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. Its market and sell products to hospitals, ambulatory surgery centers, and healthcare providers in the United States.
What is the stock price of SURGALIGN HOLDINGS INC today?
The current stock price of SRGA is 0.1829 USD. The price decreased by -32.98% in the last trading session.
What is the dividend status of SURGALIGN HOLDINGS INC?
SRGA does not pay a dividend.
What is the ChartMill technical and fundamental rating of SRGA stock?
SRGA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the analyst forecast for SRGA stock?
10 analysts have analysed SRGA and the average price target is 2.3 USD. This implies a price increase of 1154.78% is expected in the next year compared to the current price of 0.1829.
Is SURGALIGN HOLDINGS INC (SRGA) expected to grow?
The Revenue of SURGALIGN HOLDINGS INC (SRGA) is expected to decline by -37.13% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the market cap for SURGALIGN HOLDINGS INC?
SURGALIGN HOLDINGS INC (SRGA) has a market capitalization of 1.68M USD. This makes SRGA a Nano Cap stock.